Address:
280 King of Prussia Road
Radnor, PA 19087
United States (National)
Partner: Darren Check
Contact this Practitioner
Number of Partners: 33
Number of Attorneys: 83
Languages: English, Spanish, German
Kessler Topaz Meltzer & Check, LLP is one of the largest firms in the world specializing in the prosecution of complex litigation on a contingent basis. Kessler Topaz has developed a worldwide reputation for excellence in the areas of securities, shareholder, and consumer class actions. With offices in Radnor, Pennsylvania (Headquarters) and San Francisco, California, Kessler Topaz is comprised of a highly skilled team of attorneys, paralegals, in-house investigators, legal clerks and other personnel. The Firm proudly notes that it has recovered billions of dollars on behalf of its clients.
With a large and sophisticated client base of over 350 institutional investors, Kessler Topaz has been entrusted to lead some of the most important actions being litigated in our field today. These clients include public, private, and Taft-Hartley pension funds, asset managers, hedge funds, insurance companies, sovereign wealth funds, and more.
Kessler Topaz’s shareholder litigation practice focuses on the prosecution of securities fraud claims brought against public companies as well as their officers, directors, and advisors. We currently serve as lead or co-lead counsel in many of the largest and most significant securities and shareholder derivative actions pending in the United States.
Kessler Topaz’s Corporate Governance and Mergers & Acquisitions Department represents investors in shareholder derivative and class actions arising from a wide-range of misconduct, including self-interested M&A transactions or corporate reorganizations, executive compensation abuses, shareholder disenfranchisement, and board entrenchment.
In addition, Kessler Topaz currently serves as lead or co-lead counsel in many of the largest consumer and antitrust actions pending in the United States, including cases against many of the massive pharmaceutical companies for employing illegal pay-for-delay schemes. Previously, we brought and resolved proprietary actions on behalf of institutional investors against numerous banks for foreign exchange rate violations, breaches of securities lending agreements, and violations of consumer protection statutes.
Notably, the Firm has also been at the forefront of representing institutional investors in non-U.S. jurisdictions following the Supreme Court’s 2010 decision in Morrison v. National Australia Bank, which effectively closed American courts to foreign plaintiffs who invest abroad. The Firm has previously or is currently representing institutional investors in actions in the Netherlands, France, Canada, Australia, the United Kingdom, Germany, Japan, Sweden, Denmark, Italy, Israel, Taiwan, Brazil, Portugal and Cyprus.
Landmark Results:
$3.2 billion in Tyco International Ltd. Securities Litigation
$2.425 billion in Bank of America/Merrill Securities Litigation
$2 billion in Southern Peru Copper Corp. in Corporate Governance & M+A Litigation
$1.6 billion in Steinhoff International Holdings N.V. Global Securities Litigation
$1.36 billion (€1.204 billion) in Fortis Bank Global Securities Litigation
$730 million in Citigroup Bonds Securities Litigation
$627 million in Wachovia Preferred Securities Litigation
$612.5 million in Fannie Mae/Freddie Mac Corporate Governance & M+A Litigation
$616 million in Lehman Brothers Securities Litigation
$504 million in BNY Mellon FX Fiduciary Litigation
$500 million in Countrywide Financial Corp. Securities Litigation
$486 million in Pfizer, Inc. Securities Litigation
$450 million in Kraft Heinz Company Securities Litigation
$290 million in Allergan Inc. Securities Litigation
$150 million in Flonase Antitrust Litigation
$148 million in Dole Food Company in Corporate Governance & M+A Litigation
$1 billion (£900 million) in Royal Bank of Scotland Global Securities Litigation
$450 million (€323.8 million) in Royal Dutch Shell Global Securities Litigation
Practice Areas:
Updated Sep 2024